Meterbolic has been a leader for years in metabolic health measurement. Our breakthrough KRAFT TEST® maps insulin and glucose responses with unmatched precision, detecting metabolic dysfunction years before standard diagnostics. This unique science empowers individuals and corporations to prevent diabetes, cardiovascular disease, Alzheimer’s, and many cancers — conditions that have become the silent epidemic of our age.
We are now leveraging this scientific leadership to move to the frontier of generative AI and insurtech. Our next phase combines metabolic testing with an AI-driven health platform that delivers data-led lifestyle therapy, continuous risk stratification, and underwriting tools for corporate healthcare and insurance.
Meterbolic is building a new category in healthcare: quantitative, computational biology applied to real-world health and financial outcomes.